SEQUENT SCIENTIFIC
|
The Current P/S Ratio of SEQUENT SCIENTIFIC is 4.61.
| Share Price | ₹224.5 | May 15,2026 |
| Market Cap | ₹9,806.2 Cr | |
| Sales-TTM | ₹2,125.5 Cr | TTM-Consolidated Results |
| Price/Sales | 4.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SEQUENT SCIENTIFIC
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹9,806.2 Cr] as on May 15,2026
(/) Sales [ ₹2,125.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.61x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay '4.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SEQUENT SCIENTIFIC !
The chart below summarizes the trend in P/S Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PS (Price/Sales) ratio chart of SEQUENT SCIENTIFIC
PS Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.44x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 2.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2021 at 4.39x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2023 of 1.27x.
How does SEQUENT SCIENTIFIC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SEQUENT SCIENTIFIC | 2,125.5 | 4.61 | 9,806.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.94 | 451,075.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.40 | 179,486.0 |
| CIPLA LTD | 28,162.6 | 4.11 | 115,641.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.70 | 149,124.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.31 | 111,589.0 |
| MANKIND PHARMA LTD | 13,914.1 | 7.43 | 103,368.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.90 | 101,755.0 |
| LUPIN LTD | 27,958.0 | 3.72 | 103,966.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.65 | 87,776.5 |
| ABBOTT INDIA LTD | 6,929.1 | 8.57 | 59,359.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SEQUENT SCIENTIFIC 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.65x |
| Max industry PS | 17.40x |
| Median industry PS | 4.61x |
| Average industry PS | 6.85x |
You may also like the below Video Courses